US health insurer Aetna is close to buying rival Humana Inc (HUM.N) and a deal could be signed as early as this weekend, Bloomberg reported, citing people familiar with the matter.
Humana has also received an offer from Cigna but Humana’s board prefers the offer from Aetna, Bloomberg reported.
Aetna and Humana were in talks, a source familiar with the matter told Reuters on Thursday, adding that there was no certainty Aetna would prevail. Cigna is also in the running.
Aetna made a formal bid this week in the form of cash and stock, the people said. While the exact offer details weren’t available, any proposal would probably value Humana above its $28 billion market capitalization as of Wednesday’s close.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Microsoft Faces EU Antitrust Charges Over Teams Software
May 13, 2024 by
CPI
EU Antitrust Complaint Filed Against Edwards Lifesciences by Indian Rival Meril
May 13, 2024 by
CPI
South Korea’s Antitrust Watchdog Partners with AliExpress and Temu to Address Safety Concerns
May 13, 2024 by
CPI
EU Designates Booking.com as ‘Gatekeeper’ Under Digital Markets Act
May 13, 2024 by
CPI
US Airlines Challenge Biden Administration Over New Airfare Fee Disclosure Rule
May 13, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI